ketanserin has been researched along with Prostatic Hyperplasia in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hørby, J | 1 |
Gyrtrup, HJ | 1 |
Frimodt-Møller, C | 2 |
Mathiesen, FR | 2 |
Hørby-Petersen, J | 1 |
Schmidt, PF | 1 |
Meyhoff, HH | 1 |
2 other studies available for ketanserin and Prostatic Hyperplasia
Article | Year |
---|---|
The effect of a serotonin antagonist ketanserin on acute urinary retention.
Topics: Acute Disease; Aged; Humans; Ketanserin; Male; Prostatic Hyperplasia; Urination Disorders; Urine | 1989 |
The effects of a new serotonin receptor antagonist (ketanserin) on lower urinary tract function in patients with prostatism.
Topics: Aged; Blood Pressure; Humans; Ketanserin; Male; Middle Aged; Piperidines; Pressure; Prostatic Hyperp | 1985 |